Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06982235 · ClinicalTrials.gov registry record
Stone and Laser Therapies Post-Market Study (SALT)
A clinical trial of Renal Calculi and Benign Prostate Hypertrophy(BPH), sponsored by Boston Scientific Corporation.
- Recruiting
- Registry status
- 238
- Enrollment target
- 5
- Study locations
NCT06982235: Recruiting study of Renal Calculi and Benign Prostate Hypertrophy(BPH), sponsored by Boston Scientific Corporation.
NCT06982235 is a study of Renal Calculi and Benign Prostate Hypertrophy(BPH) that is actively recruiting participants, run by Boston Scientific Corporation. The registered enrollment target is 238 participants, above the 207-participant average among 4 other Renal Calculi trials with a reported enrollment target (15% higher). The trial reports 5 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06982235, a study of Renal Calculi and Benign Prostate Hypertrophy(BPH), is actively recruiting participants, sponsored by Boston Scientific Corporation.
- RECRUITING
- Registry status
- 238 participants
- Enrollment target
- 5
- Study locations
Study Summary
The objective of the SALT Study is to obtain post-market safety and device performance data for Boston Scientific's Stone and BPH study devices used during a diagnostic and/or therapeutic urinary tract procedure (e.g., transurethral or percutaneous access routes) or benign prostatic hyperplasia (BPH) treatment.
Primary Outcome
The primary endpoint is the occurrence of serious adverse events related to BSC study devices.
Conditions Studied
Interventions
- DEVICE Ureteroscope system
- DEVICE Laser system
Study Locations (5)
Florida
- University of Miami Hospital - Miami
- University of South Florida - Tampa
Arizona
- Mayo Clinic Phoenix - Phoenix
Indiana
- Indiana University Medical Center - Indianapolis
North Carolina
- Duke University Medical Center - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 238 participants |
| Start Date | 2025-06-30 |
| Est. Completion | 2029-02 |
What NCT06982235 shows while recruiting
NCT06982235 is an observational study that tracks outcomes without assigning an intervention. The registered 238 participants enrollment target is mid-sized for trials with a published cap, above the 207-participant average among 4 other Renal Calculi trials with a reported enrollment target (15% higher).
The record links to 5 conditions, with Renal Calculi appearing as the primary indexed condition, and to 2 interventions - of which Ureteroscope system is the first listed.
NCT06982235 lists 5 locations in 4 states (Florida, Arizona, Indiana).
Frequently Asked Questions
What is clinical trial NCT06982235 about?
NCT06982235 is a clinical study titled "Stone and Laser Therapies Post-Market Study (SALT)". The objective of the SALT Study is to obtain post-market safety and device performance data for Boston Scientific's Stone and BPH study devices used during a diagnostic and/or therapeutic urinary tract procedure (e.g., transurethral or percutaneous access routes) or benign prostatic hyperplasia (BPH...
What is the current status of trial NCT06982235?
This trial is currently recruiting. The enrollment target is 238 participants. The study started on 2025-06-30. Estimated completion is 2029-02.
What conditions does trial NCT06982235 study?
This clinical trial studies the following conditions: Renal Calculi, Benign Prostate Hypertrophy(BPH), Ureteral Stones, Kidney Stones, Calculi, Urinary, Urinary Tract Procedure.
What interventions are being tested in trial NCT06982235?
The interventions under investigation include: Ureteroscope system (DEVICE), Laser system (DEVICE).
Who is sponsoring clinical trial NCT06982235?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06982235 being conducted?
This trial has 5 study locations across Arizona, Florida, Indiana, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Renal Calculi
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Break Wave(TM) Extracorporeal Lithotripter First-in-Human Study
RECRUITING · NA
-
Intraoperative Assessment of of Burst Wave Lithotripsy (BWL)
ACTIVE NOT RECRUITING · NA
-
Randall's Plaque Study: Pathogenesis and Relationship to Nephrolithiasis
ACTIVE NOT RECRUITING · NA
-
SOUND Pivotal Trial - (Sonomotion stOne comminUtion resoNance ultrasounD)
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05012072 · 238 participants · NA
Reducing Pregnancy Risks: The Mastery Lifestyle Intervention
- NCT05400252 · 238 participants · NA
Whole Health in VA Mental Health: Omnis Salutis
- NCT06380517 · 238 participants · Phase 3
Dichoptic Treatment for Amblyopia in Children 4 to 7 Years of Age
- NCT06452797 · 238 participants · NA
Prognostic Estimates Among ICU Clinicians
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI